8:30 AM – 9:30 AM
AML
Moderator: Gabriel Ghiaur, MD
8:30 – 8:50
April 16th
Christoph Röllig, MD
How to treat FLT3 AML in 2026
University Hospital TU Dresden, Dresden, Germany
8:50 – 9:10
April 16th
Marina Konopleva, MD
BCL-2 inhibition in AML: successes and challenges
Montefiore Einstein Comprehensive Cancer Center, New York, USA
9:10 – 9:30
April 16th
Ivana Gojo, MD
Immune therapies in AML
Johns Hopkins University, Leukemia Program, Baltimore, MD, USA
9:30 – 9:40
April 16th
Coffee Break
9:40 – 10:00
April 16th
AstraZeneca Symposium
Horia Bumbea, MD
Calqunce ECHO in Mantle Cell Lymphoma
10:00 – 10:20
April 16th
Johnson & Johnson Symposium
Ioan Macarie MD
I+V: Uniquely built. Strong performance
Târgu Mureș Emergency University Hospital
10:20 AM – 12:00 PM
Cell Therapies
Moderator: Challice Lee Bonifant
10:20 – 10:35
April 16th
Session Introduction — Moderator: Challice Lee Bonifant
10:35 – 10:50
April 16th
Hermann Einsele, MD — online talk
Cellular Therapies in MM
University of Würzburg, Germany
10:50 – 11:05
April 16th
Leo Luznik, MD
Johns Hopkins University, Baltimore, USA
11:05 – 11:20
April 16th
Sebastian Kobold, MD, PhD
Antibody-adapter-based cellular therapies for acute myeloid leukemia
University Hospital of Ludwig-Maximilian University, Munich, Germany
11:20 – 11:40
April 16th
Challice Lee Bonifant, MD, PhD
Johns Hopkins University, Baltimore, MD, USA
11:40 – 12:00
April 16th
Alina Tanase, MD
The CAR-T Access Gap in Europe: Why Geography Still Determines Patient Outcomes
Fundeni Clinical Institute, Bucharest, Romania
12:00 PM – 2:30 PM
Symposiums & Lunch
12:00 – 1:00
April 16th
Astellas Symposium
1:00 – 1:20
April 16th
Novartis Symposium
Ioana Ionița, MD
Hematology Department of Municipal Clinical Emergency Hospital of Timisoara
Advances in first-line therapy of CML - Scemblix - ASC4FIRST
1:20 – 1:40
April 16th
Roche Symposium
1:40 – 2:30
April 16th
Lunch Break
2:30 PM – 5:40 PM
Coagulation & Rare Diseases
Moderator: Ciprian Tomuleasa MD
2:30 – 3:15
April 16th
Takeda Symposium
3:15 – 3:20
April 16th
Coffee Break
3:20 – 3:40
April 16th
Popa Delia Codruța
Flow Cytometric Monitoring of CAR-T Cell Therapy: Tracking Immune Dynamics and Relapse Risk
Fundeni Clinical Institute, Bucharest, Romania
3:40 – 4:00
April 16th
Sonata Saulyte Trakymiene, MD PhD
Online talk
Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
4:00 – 4:20
April 16th
Imre Bodó, MD, PhD, DSc
Semmelweis University, Budapest, Hungary
4:20 – 4:40
April 16th
Ioana Ionița, MD
Victor Babeș University of Medicine, Timișoara, Romania
4:40 – 5:00
April 16th
Bruno Fattizzo, MD
Online talk
University of Milano, Italy
5:00 – 5:20
April 16th
AstraZeneca Symposium
Ciprian Tomuleasa MD
Fit & Young & Free, Calquence and Fix Duration Therapy in Chronic Lymphocytic Leukemia
Department of Hematology – Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
5:20 – 5:40
April 16th
Sanofi Symposium
Ciprian Tomuleasa MD
Caplacizumab Use in Immune-mediated Thrombotic Thrombocytopenic Purpura: An International Multicentre Retrospective Cohort Study (The Capla 1000+ project)
Department of Hematology – Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
5:40 PM – 6:10 PM
Closing Symposiums
5:40 – 6:00
April 16th
Servier Symposium
6:00 – 6:10
April 16th
SunWave Pharma Symposium